Clinical And Molecular Hepatology

Clinical And Molecular Hepatology

临床和分子肝病学

  • 1区 中科院分区
  • Q1 JCR分区

期刊简介

《Clinical And Molecular Hepatology》是由Korean Association for the Study of the Liver出版社于2012年创办的英文国际期刊(ISSN: 2287-2728,E-ISSN: 2287-285X),该期刊长期致力于胃肠肝病学领域的创新研究,主要研究方向为Medicine-Hepatology。作为SCIE收录期刊(JCR分区 Q1,中科院 1区),本刊采用OA开放获取模式(OA占比1%),以发表胃肠肝病学领域等方向的原创性研究为核心(研究类文章占比27.85%%)。凭借严格的同行评审与高效编辑流程,期刊年载文量精选控制在79篇,确保学术质量与前沿性。成果覆盖Web of Science、Scopus等国际权威数据库,为学者提供推动医学领域高水平交流平台。

投稿咨询

投稿提示

Clinical And Molecular Hepatology审稿周期约为 10 Weeks 。该刊近年未被列入国际预警名单,年发文量约79篇,录用竞争适中,主题需确保紧密契合医学前沿。投稿策略提示:避开学术会议旺季投稿以缩短周期,语言建议专业润色提升可读性。

  • 医学 大类学科
  • English 出版语言
  • 是否预警
  • SCIE 期刊收录
  • 79 发文量

中科院分区

中科院 SCI 期刊分区 2023年12月升级版

Top期刊 综述期刊 大类学科 小类学科
医学
1区
GASTROENTEROLOGY & HEPATOLOGY 胃肠肝病学
2区

中科院 SCI 期刊分区 2022年12月升级版

Top期刊 综述期刊 大类学科 小类学科
医学
2区
GASTROENTEROLOGY & HEPATOLOGY 胃肠肝病学
2区

JCR分区

按JIF指标学科分区 收录子集 分区 排名 百分位
学科:GASTROENTEROLOGY & HEPATOLOGY SCIE Q1 6 / 143

96.2%

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:GASTROENTEROLOGY & HEPATOLOGY SCIE Q1 11 / 143

92.66%

CiteScore

CiteScore SJR SNIP CiteScore 排名
CiteScore:15.6 SJR:3.128 SNIP:2.263
学科类别 分区 排名 百分位
大类:Biochemistry, Genetics and Molecular Biology 小类:Molecular Biology Q1 34 / 410

91%

大类:Biochemistry, Genetics and Molecular Biology 小类:Hepatology Q1 9 / 82

89%

期刊发文

  • Baveno-VII criteria to predict decompensation and initiate non-selective beta-blocker in compensated advanced chronic liver disease patients

    Author: Wong, Yu Jun; Chen, Zhaojin; Tosetti, Guilia; Degasperi, Elisabetta; Sharma, Sanchit; Agarwal, Samagra; Chuan, Liu; Huak, Chan Yiong; Jia, Li; Qi, Xiaolong; Saraya, Anoop; Primignani, Massimo

    Journal: CLINICAL AND MOLECULAR HEPATOLOGY. 2023; Vol. 29, Issue 1, pp. -. DOI: 10.3350/cmh.2022.0181

  • Hepatitis B virus pre-genomic RNA and hepatitis B core-related antigen reductions at week 4 predict favourable hepatitis B surface antigen response upon long-term nucleos(t)ide analogue in chronic hepatitis B

    Author: Mak, Lung-Yi; Wong, Danny; Kuchta, Alison; Hilfiker, Martina; Hamilton, Aaron; Chow, Ning; Mao, XianHua; Seto, Wai Kay; Yuen, Man-Fung

    Journal: CLINICAL AND MOLECULAR HEPATOLOGY. 2023; Vol. 29, Issue 1, pp. -. DOI: 10.3350/cmh.2022.0172

  • Screening strategy for non-alcoholic fatty liver disease

    Author: Zhang, Saisai; Mak, Lung-Yi; Yuen, Man-Fung; Seto, Wai-Kay

    Journal: CLINICAL AND MOLECULAR HEPATOLOGY. 2023; Vol. 29, Issue , pp. S103-S122. DOI: 10.3350/cmh.2022.0336

  • Non-invasive biomarkers for liver inflammation in non-alcoholic fatty liver disease: present and future

    Author: Yip, Terry Cheuk-Fung; Lyu, Fei; Lin, Huapeng; Li, Guanlin; Yuen, Pong-Chi; Wong, Vincent Wai-Sun; Wong, Grace Lai-Hung

    Journal: CLINICAL AND MOLECULAR HEPATOLOGY. 2023; Vol. 29, Issue , pp. S171-S183. DOI: 10.3350/cmh.2022.0426

  • Surveillance of the progression and assessment of treatment endpoints for nonalcoholic steatohepatitis

    Author: Shi, Yi-Wen; Fan, Jian-Gao

    Journal: CLINICAL AND MOLECULAR HEPATOLOGY. 2023; Vol. 29, Issue , pp. S228-S243. DOI: 10.3350/cmh.2022.0401

  • Non-alcoholic fatty liver disease: the pathologist's perspective

    Author: Leow, Wei-Qiang; Chan, Anthony Wing-Hung; Mendoza, Paulo Giovanni L.; Lo, Regina; Yap, Kihan; Kim, Haeryoung

    Journal: CLINICAL AND MOLECULAR HEPATOLOGY. 2023; Vol. 29, Issue , pp. S302-S318. DOI: 10.3350/cmh.2022.0329

  • MAFLD: How is it different from NAFLD?

    Author: Gofton, Cameron; Upendran, Yadhavan; Zheng, Ming-Hua; George, Jacob

    Journal: CLINICAL AND MOLECULAR HEPATOLOGY. 2023; Vol. 29, Issue , pp. S17-S31. DOI: 10.3350/cmh.2022.0367